| Name |
|---|
DPCR1 Genediffuse panbronchiolitis critical region 1 Predicted to be located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
LOC100631346 Genediffuse panbronchiolitis critical region 1 pseudogene |
LOC100631344 Genediffuse panbronchiolitis critical region 1 pseudogene |
LOC100631345 Genediffuse panbronchiolitis critical region 1 pseudogene |
LOC100631343 Genediffuse panbronchiolitis critical region 1 pseudogene |
MS Genemultiple sclerosis |
TSC1 Genetuberous sclerosis 1 This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022] |
TSC2 Genetuberous sclerosis 2 This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022] |
ALS2CR11 Geneamyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 11 An autosomal recessive form of juvenile amyotrophic lateral sclerosis was originally mapped to a region of chromosome 2 that includes this gene. The encoded protein contains a calcium-dependent membrane targeting C2 domain. This domain is often found in proteins that are involved in membrane trafficking and signal transduction. [provided by RefSeq, Jun 2016] |
ALS2CR12 Geneamyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12 Predicted to be located in cytoplasmic vesicle and outer dense fiber. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Mar 2025] |
PLSA1 GenePrimary lateral sclerosis, adult, 1 |
PKDTS Genepolycystic kidney disease, infantile severe, with tuberous sclerosis |
MS4 GeneMultiple sclerosis, susceptiblity to, 4 |
MS3 GeneMultiple sclerosis, susceptibility to, 3 |
MS2 GeneMultiple sclerosis, susceptibility to, 2 |
ALS7 Geneamyotrophic lateral sclerosis 7 |
ALS5 Geneamyotrophic lateral sclerosis 5 |
ALS2 Geneamyotrophic lateral sclerosis 2 (juvenile) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008] |
ALS3 Geneamyotrophic lateral sclerosis 3 (autosomal dominant) |
LOC644462 Geneamyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 2 pseudogene |
SSD GeneSpeech-sound disorder |
OHDS GeneOrthostatic hypotensive disorder of Streeten |
MAFD9 GeneMajor affective disorder-9, susceptibility to |
MAFD8 GeneMajor affective disorder-8, susceptibility to |
MAFD5 GeneMajor affective disorder 5 |
MAFD1 Genemajor affective disorder 1 |
MAFD3 GeneMajor affective disorder 3, early onset |
MDD2 GeneMajor depressive disorder 2 |
MDD1 GeneMajor depressive disorder |
MAFD2 Genemajor affective disorder 2 |
MAFD4 GeneMajor affective disorder 4 |
MAFD6 GeneMajor affective disorder 6 |
ADHD2 GeneAttention deficit-hyperactivity disorder, susceptibility to, 2 |
HDL3 GeneHuntington-like neurodegenerative disorder 2 |
PAND1 GenePanic disorder 1 |
PAND2 Genepanic disorder 2 |
PAND3 Genepanic disorder 3 |
BDET GeneBleeding disorder, east Texas type |
ADHD4 GeneAttention deficit-hyperactivity disorder, susceptibility to, 4 |
ADHD5 GeneAttention deficit-hyperactivity disorder, susceptibility to, 5 |
ADHD6 GeneAttention deficit-hyperactivity disorder, susceptibility to, 6 |
ADHD1 GeneAttention deficit-hyperactivity disorder, susceptibility to, 1 |
ADHD3 GeneAttention deficit-hyperactivity disorder, susceptibility to, 2 |
SCZD8 Geneschizophrenia disorder 8 |
SCZD7 Geneschizophrenia disorder 7 |
SCZD6 Geneschizophrenia disorder 6 |
SCZD1 Geneschizophrenia disorder 1 |
SCZD3 Geneschizophrenia disorder 3 |
SCZD10 Geneschizophrenia disorder 10 (periodic catatonia) |
NDNC9 GeneNail disorder, nonsyndromic congenital, 9 |
CLA3 Genecerebellar ataxia 3 (cerebellar parenchyma disorder 1) |
SCZD2 Geneschizophrenia disorder 2 |
PDR Genepigment disorder, reticulate |